US FDA approves expanded use of Mirum’s liver disease drug

March 13 (Reuters) – The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals’ oral drug to treat itching caused by a liver disorder in patients aged five years and older, the company said on Wednesday. (Reporting by Puyaan Singh, Pratik Jain and Mariam Sunny in Bengaluru; Editing by Shounak Dasgupta)

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html